A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses

Donata de Marco, Nicola Clementi, Nicasio Mancini, Laura Solforosi, Guisella J. Moreno, Xiangjie Sun, Terrence M. Tumpey, Larisa V. Gubareva, Vasiliy Mishin, Massimo Clementi, Roberto Burioni

Research output: Contribution to journalArticle

Abstract

Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies directed against the hemagglutinin (HA) glycoprotein. However, their high genetic variability allows the virus to evade the host immune response and the potential protection offered by seasonal vaccines. The emergence of resistance to antiviral drugs in recent years further limits the options available for the control of influenza. The development of alternative strategies for influenza prophylaxis and therapy is therefore urgently needed. In this study, we describe a human monoclonal antibody (PN-SIA49) that recognizes a highly conserved epitope located on the stem region of the HA and able to neutralize a broad spectrum of influenza viruses belonging to different subtypes (H1, H2 and H5). Furthermore, we describe its protective activity in mice after lethal challenge with H1N1 and H5N1 viruses suggesting a potential application in the treatment of influenza virus infections.

Original languageEnglish
Article numbere34415
JournalPLoS One
Volume7
Issue number4
DOIs
Publication statusPublished - Apr 4 2012

Fingerprint

H5N1 Subtype Influenza A Virus
H1N1 Subtype Influenza A Virus
Orthomyxoviridae
Viruses
Influenza A virus
neutralization
monoclonal antibodies
Monoclonal Antibodies
Hemagglutinins
hemagglutinins
influenza
Human Influenza
mice
Viral Drug Resistance
antiviral agents
viruses
Pandemics
pandemic
Virus Diseases
Humoral Immunity

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. / de Marco, Donata; Clementi, Nicola; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Sun, Xiangjie; Tumpey, Terrence M.; Gubareva, Larisa V.; Mishin, Vasiliy; Clementi, Massimo; Burioni, Roberto.

In: PLoS One, Vol. 7, No. 4, e34415, 04.04.2012.

Research output: Contribution to journalArticle

de Marco, Donata ; Clementi, Nicola ; Mancini, Nicasio ; Solforosi, Laura ; Moreno, Guisella J. ; Sun, Xiangjie ; Tumpey, Terrence M. ; Gubareva, Larisa V. ; Mishin, Vasiliy ; Clementi, Massimo ; Burioni, Roberto. / A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. In: PLoS One. 2012 ; Vol. 7, No. 4.
@article{e2185c572b3c4183bf331add2cdca0c7,
title = "A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses",
abstract = "Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies directed against the hemagglutinin (HA) glycoprotein. However, their high genetic variability allows the virus to evade the host immune response and the potential protection offered by seasonal vaccines. The emergence of resistance to antiviral drugs in recent years further limits the options available for the control of influenza. The development of alternative strategies for influenza prophylaxis and therapy is therefore urgently needed. In this study, we describe a human monoclonal antibody (PN-SIA49) that recognizes a highly conserved epitope located on the stem region of the HA and able to neutralize a broad spectrum of influenza viruses belonging to different subtypes (H1, H2 and H5). Furthermore, we describe its protective activity in mice after lethal challenge with H1N1 and H5N1 viruses suggesting a potential application in the treatment of influenza virus infections.",
author = "{de Marco}, Donata and Nicola Clementi and Nicasio Mancini and Laura Solforosi and Moreno, {Guisella J.} and Xiangjie Sun and Tumpey, {Terrence M.} and Gubareva, {Larisa V.} and Vasiliy Mishin and Massimo Clementi and Roberto Burioni",
year = "2012",
month = "4",
day = "4",
doi = "10.1371/journal.pone.0034415",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses

AU - de Marco, Donata

AU - Clementi, Nicola

AU - Mancini, Nicasio

AU - Solforosi, Laura

AU - Moreno, Guisella J.

AU - Sun, Xiangjie

AU - Tumpey, Terrence M.

AU - Gubareva, Larisa V.

AU - Mishin, Vasiliy

AU - Clementi, Massimo

AU - Burioni, Roberto

PY - 2012/4/4

Y1 - 2012/4/4

N2 - Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies directed against the hemagglutinin (HA) glycoprotein. However, their high genetic variability allows the virus to evade the host immune response and the potential protection offered by seasonal vaccines. The emergence of resistance to antiviral drugs in recent years further limits the options available for the control of influenza. The development of alternative strategies for influenza prophylaxis and therapy is therefore urgently needed. In this study, we describe a human monoclonal antibody (PN-SIA49) that recognizes a highly conserved epitope located on the stem region of the HA and able to neutralize a broad spectrum of influenza viruses belonging to different subtypes (H1, H2 and H5). Furthermore, we describe its protective activity in mice after lethal challenge with H1N1 and H5N1 viruses suggesting a potential application in the treatment of influenza virus infections.

AB - Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies directed against the hemagglutinin (HA) glycoprotein. However, their high genetic variability allows the virus to evade the host immune response and the potential protection offered by seasonal vaccines. The emergence of resistance to antiviral drugs in recent years further limits the options available for the control of influenza. The development of alternative strategies for influenza prophylaxis and therapy is therefore urgently needed. In this study, we describe a human monoclonal antibody (PN-SIA49) that recognizes a highly conserved epitope located on the stem region of the HA and able to neutralize a broad spectrum of influenza viruses belonging to different subtypes (H1, H2 and H5). Furthermore, we describe its protective activity in mice after lethal challenge with H1N1 and H5N1 viruses suggesting a potential application in the treatment of influenza virus infections.

UR - http://www.scopus.com/inward/record.url?scp=84859364851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859364851&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0034415

DO - 10.1371/journal.pone.0034415

M3 - Article

C2 - 22496802

AN - SCOPUS:84859364851

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e34415

ER -